HCW Biologics Inc. Public Float
HCW Biologics Inc. (HCWB) had Public Float of $6.20 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $6.20M.
- 2024-06-28: Entity Public Float $12.80M.
- 2023-06-30: Entity Public Float $42.80M.
- 2022-06-30: Entity Public Float $44.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.20M 10-K · filed 2026-03-31 |
| 2024-06-28 | $12.80M 10-K · filed 2025-03-28 |
| 2023-06-30 | $42.80M 10-K/A · filed 2024-05-15 |
| 2022-06-30 | $44.10M 10-K · filed 2023-03-28 |
| 2021-07-22 | $91.40M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |